Dosimetric impact of tracheostomy devices in head and neck cancer patients
Open Access
- 1 June 2020
- journal article
- research article
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (6), 26-32
- https://doi.org/10.1002/acm2.12862
Abstract
Introduction The tracheostomy site and adjacent skin is at risk for recurrence in head/neck squamous cell cancer patients. The tracheostomy tube is an in situ device located directly over the tracheostomy site and may have clinical implications on the radiation dose delivered to the peristomal region. This study aimed to investigate this effect by comparing the prescribed treatment planning dose with the actual dose in vivo to the peristomal clinical target region. A retrospective, dosimetric study was performed with approval of the institutional research ethics board. Methods Fifteen patients who had received high-dose radiotherapy to the tracheostomy region with in vivo dose measurements were included. The radiation dose at the skin surface underneath the tracheostomy device was measured using an optically stimulated luminescent dosimeter (OSLD) and was compared with the prescribed dose from the radiation planning system. The effect of the tracheostomy flange and/or soft tissue equivalent bolus on the peristomal dose was calculated. Results and discussion Patients with tracheostomy equipment in situ were found to have a 3.7% difference between their prescribed and actual dose. With a tissue equivalent bolus there was a 2.0% difference between predicted and actual. The mean prescribed single fraction dose (mean = 191.8 cGy, SD = 40.18) and OSLD measured dose (mean = 194.02 cGy, SD = 44.3) were found to have no significant difference. However, with the flange excluded from the planning simulation (density = air) target skin dose deviated from predicted by an average of 55.3% (range = 12.4-72.9, SD = 22.5) and volume coverage was not achieved. Conclusion In summary, the tracheostomy flange acts like bolus with a twofold increase in the skin surface dose. Changes in the peristomal apparatus from simulation to treatment needs to be considered to ensure that the simulated dose and coverage is achieved.Keywords
This publication has 29 references indexed in Scilit:
- Review of optically stimulated luminescence (OSL) instrumental developments for retrospective dosimetryRadiation Measurements, 2010
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)International Journal of Radiation Oncology*Biology*Physics, 2010
- Dosimetric effects near implanted vascular access ports: an examination of external photon beam dose calculationsJournal of Applied Clinical Medical Physics, 2009
- Optically stimulated luminescence (OSL) dosimetry in medicinePhysics in Medicine & Biology, 2008
- Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckHead & Neck, 2007
- Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRTJournal of Applied Clinical Medical Physics, 2006
- Archimedes revisited: a faster, better, cheaper method of accurately measuring the volume of small objectsPhysics Education, 2005
- A Fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimizationMedical Physics, 2005
- Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73–03 of the radiation therapy oncology groupHead & Neck Surgery, 1987